August 2023

Features

Expanding Retina’s Armamentarium

Here’s how specialists are using the latest treatments for wet AMD, DME and RVO.

Will Complement Therapy Catch On?

With one FDA-approved geographic atrophy therapy available (and another one not far behind), retina specialists are hopeful for the benefit to patients, while some remain cautious.

An Update on Office-Based Surgery

Ophthalmologists discuss the pros and cons of office-based surgery suites.

Whither Presbyopia Eye Drops?

Vuity is struggling on the market, but it might not be the end of presbyopia-correcting eye drops. Here’s a look at the current market and pipeline.

Departments

Review News

Study Finds Low-dose Atropine Ineffective vs. Myopia

Medicare Q & A

A Review of the 21st Century Cures Act

We answer the burning questions that have arisen since the Act’s going into effect in 2019.

Retinal Insider

A Review of Genetic Testing and Counseling

A look at the current state of genetic counseling, the methods that are available, and what might be coming in the future.

Refractive/Cataract Rundown

Lessons on Clear Lens Extraction

IOL technologies are creating more appeal for refractive lens exchange. Here’s guidance on patient selection.

Glaucoma Management

Antithrombotics and Glaucoma Surgery

Weighing the pros and cons of altering therapy involves several factors. Here’s guidance for management.

Cornea/Anterior Segment

Highlights from the TFOS Lifestyle Reports

A selection of key takeaways from the largest global dry-eye panel to date.

Research Review

Predictive Factors for Advanced AMD

The Forum

Another July

Musings on life, ophthalmology and the practice of medicine.

Wills Eye Resident Case Series

August 2023 Wills Eye Resident Case Series

A 63-year-old with vision loss presents at Wills Eye Hospital.

Current Issue